These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19738023)

  • 1. Emergence of an Enterobacter hormaechei strain with reduced susceptibility to tigecycline under tigecycline therapy.
    Daurel C; Fiant AL; Brémont S; Courvalin P; Leclercq R
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4953-4. PubMed ID: 19738023
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of Etest to determine tigecycline MICs for Enterobacter species.
    Cohen Stuart J; Mouton JW; Diederen BM; Al Naiemi N; Thijsen S; Vlaminckx BJ; Fluit AC; Leverstein-van Hall MA
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2746-7. PubMed ID: 20350941
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro activity of tigecycline against carbapenem-susceptible and -resistant isolates of Klebsiella spp. and Enterobacter spp.
    Woodford N; Hill RL; Livermore DM
    J Antimicrob Chemother; 2007 Mar; 59(3):582-3. PubMed ID: 17229831
    [No Abstract]   [Full Text] [Related]  

  • 4. Emergence of AcrAB-mediated tigecycline resistance in a clinical isolate of Enterobacter cloacae during ciprofloxacin treatment.
    Hornsey M; Ellington MJ; Doumith M; Scott G; Livermore DM; Woodford N
    Int J Antimicrob Agents; 2010 May; 35(5):478-81. PubMed ID: 20189357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group.
    Arroyo LA; Mateos I; González V; Aznar J
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1295-6. PubMed ID: 19075049
    [No Abstract]   [Full Text] [Related]  

  • 6. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Susceptibility to Tigecycline Mediated by a Mutation in mlaA in Escherichia coli Strains.
    He F; Xu J; Wang J; Chen Q; Hua X; Fu Y; Yu Y
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7530-7531. PubMed ID: 27671071
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro susceptibility of multidrug-resistant Enterobacteriaceae clinical isolates to tigecycline.
    Huang TD; Berhin C; Bogaerts P; Glupczynski Y
    J Antimicrob Chemother; 2012 Nov; 67(11):2696-9. PubMed ID: 22833638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
    Mischnik A; Baumert P; Hamprecht A; Rohde AM; Peter S; Feihl S; Knobloch J; Gölz H; Kola A; Obermann B; Querbach C; Willmann M; Gebhardt F; Tacconelli E; Gastmeier P; Seifert H; Kern WV;
    J Antimicrob Chemother; 2017 May; 72(5):1359-1363. PubMed ID: 28108677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial.
    Waites KB; Duffy LB; Dowzicky MJ
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3479-84. PubMed ID: 17005838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011).
    Sader HS; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):217-21. PubMed ID: 23522845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae.
    Keeney D; Ruzin A; Bradford PA
    Microb Drug Resist; 2007; 13(1):1-6. PubMed ID: 17536927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.
    Kanj SS; Whitelaw A; Dowzicky MJ
    Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.
    Zhang R; Cai JC; Zhou HW; Nasu M; Chen GX
    J Med Microbiol; 2011 Dec; 60(Pt 12):1813-1819. PubMed ID: 21835972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints.
    Papaparaskevas J; Tzouvelekis LS; Tsakris A; Pittaras TE; Legakis NJ;
    Diagn Microbiol Infect Dis; 2010 Feb; 66(2):187-94. PubMed ID: 19836184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial isolation and emergence of antimicrobial resistance associated with tigecycline usage.
    Chen LY; Chen TC; Chen YH; Lin CY; Lin WR; Lu PL
    J Microbiol Immunol Infect; 2011 Oct; 44(5):352-7. PubMed ID: 21524975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline.
    Fluit AC; Florijn A; Verhoef J; Milatovic D
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1636-8. PubMed ID: 15793159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acinetobacter spp. susceptibility to tigecycline: a worldwide perspective.
    Curcio D; Fernández F
    J Antimicrob Chemother; 2007 Aug; 60(2):449-50. PubMed ID: 17561503
    [No Abstract]   [Full Text] [Related]  

  • 19. ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline.
    Hentschke M; Wolters M; Sobottka I; Rohde H; Aepfelbacher M
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2720-3. PubMed ID: 20350947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Activity of Polymyxin B in Combination with Various Antibiotics against Extensively Drug-Resistant Enterobacter cloacae with Decreased Susceptibility to Polymyxin B.
    Cai Y; Lim TP; Teo J; Sasikala S; Lee W; Hong Y; Chan EC; Tan TY; Tan TT; Koh TH; Hsu LY; Kwa AL
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5238-46. PubMed ID: 27324776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.